- This line was added.
- This line was removed.
- Formatting was changed.
Diagnostic CT and PET scans from 215 head and neck squamous cell carcinoma (HNSCC) patients treated with radiation therapy (RT) at MD Anderson obtained pre-RT, post-RT and at recurrence, when applicable. Data set also includes all RT simulation, target delineation, and planning DICOM images for all patients. The CT phase of diagnostic abdominal imaging was then used to quantify body composition in these patients as part of a study into the prognostic impact of patients' muscle mass on oncologic outcomes. Accompanying clinical information includes patient and cancer characteristics, survival, recurrence, and body composition data.
This research was supported by the Andrew Sabin Family Foundation; Dr. Fuller is a Sabin Family Foundation Fellow. Drs. Mohamed and Fuller receive funding support from the National Institutes of Health (NIH)/National Institute for Dental and Craniofacial Research (NIDCR) (R01DE025248) and the National Institutes of Health (NIH)/National Cancer Institute (NCI) (1R01CA214825-01). Dr. Fuller received/(s) grant and/or salary support from the NIH/NCI Head and Neck Specialized Programs of Research Excellence (SPORE) Developmental Research Program Career Development Award (P50CA097007-10); the NCI Paul Calabresi Clinical Oncology Program Award (K12 CA088084-06); a General Electric Healthcare/MD Anderson Center for Advanced Biomedical Imaging In-Kind Award; an Elekta AB/MD Anderson Department of Radiation Oncology Seed Grant; the Center for Radiation Oncology Research (CROR) at MD Anderson Cancer Center Seed Grant; the MD Anderson Institutional Research Grant (IRG) Program; and the NIH/NCI Cancer Center Support (Core) Grant CA016672 to The University of Texas MD Anderson Cancer Center (P30 CA016672). Dr. Elhalawani was directly funded in part by a philanthropic gift from the Family of Paul W. Beach given to Dr. Gunn for patient-outcome database construction.